Cargando…

Tau protein aggregation associated with SARS-CoV-2 main protease

The primary function of virus proteases is the proteolytic processing of the viral polyprotein. These enzymes can also cleave host cell proteins, which is important for viral pathogenicity, modulation of cellular processes, viral replication, the defeat of antiviral responses and modulation of the i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eberle, Raphael Josef, Coronado, Mônika Aparecida, Gering, Ian, Sommerhage, Simon, Korostov, Karolina, Stefanski, Anja, Stühler, Kai, Kraemer-Schulien, Victoria, Blömeke, Lara, Bannach, Oliver, Willbold, Dieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441795/ https://www.ncbi.nlm.nih.gov/pubmed/37603556 http://dx.doi.org/10.1371/journal.pone.0288138

Ejemplares similares

Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting
por: Blömeke, Lara, et al.
Publicado: (2022)

Development and Implementation of an Internal Quality Control Sample to Standardize Oligomer-Based Diagnostics of Alzheimer’s Disease
por: Pils, Marlene, et al.
Publicado: (2023)

A Computer-Aided Approach for the Discovery of D-Peptides as Inhibitors of SARS-CoV-2 Main Protease
por: Hernández González, Jorge E., et al.
Publicado: (2022)

Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold
por: Eberle, Raphael J., et al.
Publicado: (2022)

Discovery of All-d-Peptide Inhibitors of SARS-CoV-2 3C-like Protease
por: Eberle, Raphael J., et al.
Publicado: (2023)

Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stool
por: Schaffrath, Anja, et al.
Publicado: (2023)

The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CL(pro) In Vitro
por: Eberle, Raphael J., et al.
Publicado: (2021)

Promising Natural Compounds against Flavivirus Proteases: Citrus Flavonoids Hesperetin and Hesperidin
por: Eberle, Raphael J., et al.
Publicado: (2021)

The Importance of Epigallocatechin as a Scaffold for Drug Development against Flaviviruses
por: Coronado, Mônika A., et al.
Publicado: (2023)

Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease
por: Kutzsche, Janine, et al.
Publicado: (2023)

Riboflavin, a Potent Neuroprotective Vitamin: Focus on Flavivirus and Alphavirus Proteases
por: Eberle, Raphael J., et al.
Publicado: (2022)

In vitro study of Hesperetin and Hesperidin as inhibitors of zika and chikungunya virus proteases
por: Eberle, Raphael J., et al.
Publicado: (2021)

Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay
por: Loschwitz, Jennifer, et al.
Publicado: (2021)

Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies
por: Altendorf, Tim, et al.
Publicado: (2023)

Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1(G93A) Transgenic Mice
por: Post, Julia, et al.
Publicado: (2021)

A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant
por: Sevenich, Marc, et al.
Publicado: (2022)

Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo
por: Braczynski, Anne K., et al.
Publicado: (2022)

Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment
por: Pir, Ghulam Jeelani, et al.
Publicado: (2018)

The SARS-CoV-2 main protease induces neurotoxic TDP-43 cleavage and aggregates
por: Yang, Jiaxin, et al.
Publicado: (2023)

In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease
por: Schemmert, Sarah, et al.
Publicado: (2021)

Propagation of Tau aggregates
por: Goedert, Michel, et al.
Publicado: (2017)

The GABARAP Co-Secretome Identified by APEX2-GABARAP Proximity Labelling of Extracellular Vesicles
por: Sanwald, Julia L., et al.
Publicado: (2020)

Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay
por: Kühbach, Katja, et al.
Publicado: (2016)

Sex-Related Motor Deficits in the Tau-P301L Mouse Model
por: Camargo, Luana Cristina, et al.
Publicado: (2021)

Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo
por: Kass, Bettina, et al.
Publicado: (2022)

A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease
por: Baker, Jeremy D., et al.
Publicado: (2021)

EGCG impedes human Tau aggregation and interacts with Tau
por: Sonawane, Shweta Kishor, et al.
Publicado: (2020)

Human tau pathology transmits glial tau aggregates in the absence of neuronal tau
por: Narasimhan, Sneha, et al.
Publicado: (2019)

Tau binding protein CAPON induces tau aggregation and neurodegeneration
por: Hashimoto, Shoko, et al.
Publicado: (2019)

Toxic tau: structural origins of tau aggregation in Alzheimer's disease
por: Mamun, Abdullah Al, et al.
Publicado: (2020)

Tau Phosphorylation, Aggregation, and Cell Toxicity
por: Avila, J., et al.
Publicado: (2006)

Are Tau Aggregates Toxic or Protective in Tauopathies?
por: Cowan, Catherine M., et al.
Publicado: (2013)

Structure-based inhibitors of tau aggregation
por: Seidler, PM, et al.
Publicado: (2017)

Signature of an aggregation-prone conformation of tau
por: Eschmann, Neil A., et al.
Publicado: (2017)

Pharmacological Modulators of Tau Aggregation and Spreading
por: Dominguez-Meijide, Antonio, et al.
Publicado: (2020)

Bacterial DNA promotes Tau aggregation
por: Tetz, George, et al.
Publicado: (2020)

The Significance of Tau Aggregates in the Human Brain
por: Castellani, Rudy J.
Publicado: (2020)

Cannabidiol Inhibits Tau Aggregation In Vitro
por: Alali, Soha, et al.
Publicado: (2021)

Neem Derivatives Inhibits Tau Aggregation
por: Gorantla, Nalini V., et al.
Publicado: (2021)

β-Hairpin of Islet Amyloid Polypeptide Bound to an Aggregation Inhibitor
por: Mirecka, Ewa A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m5ga2q4a2tp8h43i6dc0fhporo